{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["drug design and discovery", "hordenine", "kinase inhibitors", "lung cancer therapy", "molecular dynamics simulation", "pyruvate dehydrogenase kinase"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "32422877", "DateRevised": {"Year": "2024", "Month": "03", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "05", "Day": "14"}], "Language": ["eng"], "ELocationID": ["119", "10.3390/biomedicines8050119"], "Journal": {"ISSN": "2227-9059", "JournalIssue": {"Volume": "8", "Issue": "5", "PubDate": {"Year": "2020", "Month": "May", "Day": "14"}}, "Title": "Biomedicines", "ISOAbbreviation": "Biomedicines"}, "ArticleTitle": "Discovery of Hordenine as a Potential Inhibitor of Pyruvate Dehydrogenase Kinase 3: Implication in Lung Cancer Therapy.", "Abstract": {"AbstractText": ["Design and development of potential pyruvate dehydrogenase kinase 3 (PDK3) inhibitors have gained attention because of their possible therapeutic uses in lung cancer therapy. In the present study, the binding affinity of naturally occurring alkaloids, hordenine, vincamine, tryptamine, cinchonine, and colcemid was measured with PDK3. The molecular docking and fluorescence binding studies suggested that all these compounds show a considerable binding affinity for PDK3. Among them, the affinity of hordenine to the PDK3 was excellent (<i>K</i> = 10<sup>6</sup> M<sup>-1</sup>) which was further complemented by isothermal titration calorimetric measurements. Hordenine binds in the active site pocket of PDK3 and forms a significant number of non-covalent interactions with functionally important residues. All-atom molecular dynamics (MD) simulation study suggested that the PDK3-hordenine complex is stabilized throughout the trajectory of 100ns and leads to fewer conformational changes. The enzyme inhibition studies showed that hordenine inhibits the activity of PDK3 with an IC<sub>50</sub> value of 5.4 \u00b5M. Furthermore, hordenine showed a cytotoxic effect on human lung cancer cells (A549 and H1299) with an admirable IC<sub>50</sub> value. However, it did not inhibit the growth of HEK293 cells up to 200 \u00b5M, indicating its non-toxicity to non-cancerous cell lines. In summary, our findings provide the basis for the therapeutic implication of hordenine and its derivatives in lung cancer and PDK3-related diseases after required in vivo validation."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India."}], "LastName": "Anwar", "ForeName": "Saleha", "Initials": "S"}, {"Identifier": ["0000-0002-0399-4835"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India."}], "LastName": "Mohammad", "ForeName": "Taj", "Initials": "T"}, {"Identifier": ["0000-0001-7055-7056"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India."}], "LastName": "Shamsi", "ForeName": "Anas", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India."}], "LastName": "Queen", "ForeName": "Aarfa", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Bioprospection Department, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow 226015, India."}, {"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India."}], "LastName": "Parveen", "ForeName": "Shahnaz", "Initials": "S"}, {"Identifier": ["0000-0001-6568-8107"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Bioprospection Department, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow 226015, India."}, {"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India."}], "LastName": "Luqman", "ForeName": "Suaib", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, College of Medicine, Prince Sattam Bin Abdulaziz University, P.O. Box 173, Al-Kharj 11942, Saudi Arabia."}], "LastName": "Hasan", "ForeName": "Gulam Mustafa", "Initials": "GM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry Department, Faculty of Science, King Abdulaziz University, P.O. Box 80203, Jeddah 21589, Saudi Arabia."}], "LastName": "Alamry", "ForeName": "Khalid A", "Initials": "KA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry Department, Faculty of Science, King Abdulaziz University, P.O. Box 80203, Jeddah 21589, Saudi Arabia."}], "LastName": "Azum", "ForeName": "Naved", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry Department, Faculty of Science, King Abdulaziz University, P.O. Box 80203, Jeddah 21589, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Center of Excellence for Advanced Materials Research (CEAMR), King Abdulaziz University, P.O. Box 80203, Jeddah 21589, Saudi Arabia."}], "LastName": "Asiri", "ForeName": "Abdullah M", "Initials": "AM"}, {"Identifier": ["0000-0002-3663-4940"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India."}], "LastName": "Hassan", "ForeName": "Md Imtaiyaz", "Initials": "MI"}], "GrantList": [{"GrantID": "KEP-57-130-38", "Agency": "King Abdulaziz University", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Biomedicines", "NlmUniqueID": "101691304", "ISSNLinking": "2227-9059"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Ambinder R.F. A viral protein kinase drug target for tumors? J. Clin. Investig. 2018;128:2197\u20132198. doi: 10.1172/JCI121080.", "ArticleIdList": ["10.1172/JCI121080", "PMC5983323", "29733293"]}, {"Citation": "Ferguson F.M., Gray N.S. Kinase inhibitors: The road ahead. Nat. Rev. Drug Discov. 2018;17:353. doi: 10.1038/nrd.2018.21.", "ArticleIdList": ["10.1038/nrd.2018.21", "29545548"]}, {"Citation": "Wu P., Nielsen T.E., Clausen M.H. Small-molecule kinase inhibitors: An analysis of FDA-approved drugs. Drug Discov. Today. 2016;21:5\u201310. doi: 10.1016/j.drudis.2015.07.008.", "ArticleIdList": ["10.1016/j.drudis.2015.07.008", "26210956"]}, {"Citation": "Qi W., Keenan H.A., Li Q., Ishikado A., Kannt A., Sadowski T., Yorek M.A., Wu I.-H., Lockhart S., Coppey L.J. Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction. Nat. Med. 2017;23:753. doi: 10.1038/nm.4328.", "ArticleIdList": ["10.1038/nm.4328", "PMC5575773", "28436957"]}, {"Citation": "Gao Y.-L., Wang N., Sun F.-R., Cao X.-P., Zhang W., Yu J.-T. Tau in neurodegenerative disease. Ann. Transl. Med. 2018;6:75. doi: 10.21037/atm.2018.04.23.", "ArticleIdList": ["10.21037/atm.2018.04.23", "PMC5994507", "29951497"]}, {"Citation": "Roskoski R. Properties of FDA-approved small molecule protein kinase inhibitors. Pharmacol. Res. 2019;144:19\u201350. doi: 10.1016/j.phrs.2019.03.006.", "ArticleIdList": ["10.1016/j.phrs.2019.03.006", "30877063"]}, {"Citation": "Otto T., Sicinski P. Cell cycle proteins as promising targets in cancer therapy. Nat. Rev. Cancer. 2017;17:93. doi: 10.1038/nrc.2016.138.", "ArticleIdList": ["10.1038/nrc.2016.138", "PMC5345933", "28127048"]}, {"Citation": "Steussy C.N., Popov K.M., Bowker-Kinley M.M., Sloan R.B., Harris R.A., Hamilton J.A. Structure of pyruvate dehydrogenase kinase novel folding pattern for a serine protein kinase. J. Biol. Chem. 2001;276:37443\u201337450. doi: 10.1074/jbc.M104285200.", "ArticleIdList": ["10.1074/jbc.M104285200", "PMC2147663", "11483605"]}, {"Citation": "Harris R., Huang B., Wu P. Control of pyruvate dehydrogenase kinase gene expression. Adv. Enzym. Regul. 2001;41:269\u2013288. doi: 10.1016/S0065-2571(00)00020-0.", "ArticleIdList": ["10.1016/S0065-2571(00)00020-0", "11384751"]}, {"Citation": "Baker J.C., Yan X., Peng T., Kasten S., Roche T.E. Marked differences between two isoforms of human pyruvate dehydrogenase kinase. J. Biol. Chem. 2000;275:15773\u201315781. doi: 10.1074/jbc.M909488199.", "ArticleIdList": ["10.1074/jbc.M909488199", "10748134"]}, {"Citation": "Lu C.-W., Lin S.-C., Chien C.-W., Lin S.-C., Lee C.-T., Lin B.-W., Lee J.-C., Tsai S.-J. Overexpression of pyruvate dehydrogenase kinase 3 increases drug resistance and early recurrence in colon cancer. Am. J. Pathol. 2011;179:1405\u20131414. doi: 10.1016/j.ajpath.2011.05.050.", "ArticleIdList": ["10.1016/j.ajpath.2011.05.050", "PMC3157210", "21763680"]}, {"Citation": "Koppenol W.H., Bounds P.L., Dang C.V. Otto Warburg\u2019s contributions to current concepts of cancer metabolism. Nat. Rev. Cancer. 2011;11:325\u2013337. doi: 10.1038/nrc3038.", "ArticleIdList": ["10.1038/nrc3038", "21508971"]}, {"Citation": "Schwartz L., Supuran C.T., Alfarouk K.O. The Warburg effect and the hallmarks of cancer. Anti-Cancer Agents Med. Chem. (Former. Curr. Med. Chem. Anti-Cancer Agents) 2017;17:164\u2013170. doi: 10.2174/1871520616666161031143301.", "ArticleIdList": ["10.2174/1871520616666161031143301", "27804847"]}, {"Citation": "Lu C.-W., Lin S.-C., Chen K.-F., Lai Y.-Y., Tsai S.-J. Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance. J. Biol. Chem. 2008;283:28106\u201328114. doi: 10.1074/jbc.M803508200.", "ArticleIdList": ["10.1074/jbc.M803508200", "PMC2661383", "18718909"]}, {"Citation": "Stacpoole P.W. Therapeutic targeting of the pyruvate dehydrogenase complex/pyruvate dehydrogenase kinase (PDC/PDK) axis in cancer. JNCI J. Natl. Cancer Inst. 2017;109:11. doi: 10.1093/jnci/djx071.", "ArticleIdList": ["10.1093/jnci/djx071", "29059435"]}, {"Citation": "Woolbright B.L., Rajendran G., Harris R.A., Taylor J.A. Metabolic Flexibility in Cancer: Targeting the Pyruvate Dehydrogenase Kinase: Pyruvate Dehydrogenase Axis. Mol. Cancer Ther. 2019;18:1673\u20131681. doi: 10.1158/1535-7163.MCT-19-0079.", "ArticleIdList": ["10.1158/1535-7163.MCT-19-0079", "31511353"]}, {"Citation": "Mohammad T., Arif K., Alajmi M.F., Hussain A., Islam A., Rehman M.T., Hassan I. Identification of high-affinity inhibitors of pyruvate dehydrogenase kinase-3: Towards therapeutic management of cancer. J. Biomol. Struct. Dyn. 2020;14:1\u20139. doi: 10.1080/07391102.2020.1711810.", "ArticleIdList": ["10.1080/07391102.2020.1711810", "31903847"]}, {"Citation": "Alfarouk K.O., Stock C.-M., Taylor S., Walsh M., Muddathir A.K., Verduzco D., Bashir A.H., Mohammed O.Y., Elhassan G.O., Harguindey S. Resistance to cancer chemotherapy: Failure in drug response from ADME to P-gp. Cancer Cell Int. 2015;15:71. doi: 10.1186/s12935-015-0221-1.", "ArticleIdList": ["10.1186/s12935-015-0221-1", "PMC4502609", "26180516"]}, {"Citation": "Gupta P., Mohammad T., Dahiya R., Roy S., Noman O.M.A., Alajmi M.F., Hussain A., Hassan M.I. Evaluation of binding and inhibition mechanism of dietary phytochemicals with sphingosine kinase 1: Towards targeted anticancer therapy. Sci. Rep. 2019;9:18727. doi: 10.1038/s41598-019-55199-3.", "ArticleIdList": ["10.1038/s41598-019-55199-3", "PMC6904568", "31822735"]}, {"Citation": "Naz F., Khan F.I., Mohammad T., Khan P., Manzoor S., Hasan G.M., Lobb K.A., Luqman S., Islam A., Ahmad F., et al. Investigation of molecular mechanism of recognition between citral and MARK4: A newer therapeutic approach to attenuate cancer cell progression. Int. J. Biol. Macromol. 2018;107:2580\u20132589. doi: 10.1016/j.ijbiomac.2017.10.143.", "ArticleIdList": ["10.1016/j.ijbiomac.2017.10.143", "29079437"]}, {"Citation": "Naz H., Khan P., Tarique M., Rahman S., Meena A., Ahamad S., Luqman S., Islam A., Ahmad F., Hassan M.I. Binding studies and biological evaluation of beta-carotene as a potential inhibitor of human calcium/calmodulin-dependent protein kinase IV. Int. J. Biol. Macromol. 2017;96:161\u2013170. doi: 10.1016/j.ijbiomac.2016.12.024.", "ArticleIdList": ["10.1016/j.ijbiomac.2016.12.024", "27956097"]}, {"Citation": "Naz H., Tarique M., Ahamad S., Alajmi M.F., Hussain A., Rehman M.T., Luqman S., Hassan M.I. Hesperidin-CAMKIV interaction and its impact on cell proliferation and apoptosis in the human hepatic carcinoma and neuroblastoma cells. J. Cell Biochem. 2019;120:15119\u201315130. doi: 10.1002/jcb.28774.", "ArticleIdList": ["10.1002/jcb.28774", "31021496"]}, {"Citation": "Brami C., Bao T., Deng G. Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review. Crit. Rev. Oncol. Hematol. 2016;98:325\u2013334. doi: 10.1016/j.critrevonc.2015.11.014.", "ArticleIdList": ["10.1016/j.critrevonc.2015.11.014", "PMC4727999", "26652982"]}, {"Citation": "Gulzar M., Ali S., Khan F.I., Khan P., Taneja P., Hassan M.I. Binding mechanism of caffeic acid and simvastatin to the integrin linked kinase for therapeutic implications: A comparative docking and MD simulation studies. J. Biomol. Struct. Dyn. 2019;37:4327\u20134337. doi: 10.1080/07391102.2018.1546621.", "ArticleIdList": ["10.1080/07391102.2018.1546621", "30488773"]}, {"Citation": "Gulzar M., Syed S.B., Khan F.I., Khan P., Ali S., Hasan G.M., Taneja P., Hassan M.I. Elucidation of interaction mechanism of ellagic acid to the integrin linked kinase. Int. J. Biol. Macromol. 2019;122:1297\u20131304. doi: 10.1016/j.ijbiomac.2018.09.089.", "ArticleIdList": ["10.1016/j.ijbiomac.2018.09.089", "30227205"]}, {"Citation": "Gupta P., Mohammad T., Khan P., Alajmi M.F., Hussain A., Rehman M.T., Hassan M.I. Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: A targeted approach towards anticancer therapy. Biomed Pharm. 2019;118:109245. doi: 10.1016/j.biopha.2019.109245.", "ArticleIdList": ["10.1016/j.biopha.2019.109245", "31352240"]}, {"Citation": "Cragg G.M., Newman D.J. Plants as a source of anti-cancer agents. J. Ethnopharmacol. 2005;100:72\u201379. doi: 10.1016/j.jep.2005.05.011.", "ArticleIdList": ["10.1016/j.jep.2005.05.011", "16009521"]}, {"Citation": "Su S., Cao M., Wu G., Long Z., Cheng X., Fan J., Xu Z., Su H., Hao Y., Li G. Hordenine protects against hyperglycemia-associated renal complications in streptozotocin-induced diabetic mice. Biomed. Pharmacother. 2018;104:315\u2013324. doi: 10.1016/j.biopha.2018.05.036.", "ArticleIdList": ["10.1016/j.biopha.2018.05.036", "29775900"]}, {"Citation": "Hoffman J.R., Kang J., Ratamess N.A., Hoffman M.W., Tranchina C.P., Faigenbaum A.D. Examination of a pre-exercise, high energy supplement on exercise performance. J. Int. Soc. Sports Nutr. 2009;6:2. doi: 10.1186/1550-2783-6-2.", "ArticleIdList": ["10.1186/1550-2783-6-2", "PMC2621122", "19126213"]}, {"Citation": "Frank M., Weckman T., Wood T., Woods W., TAI C.L., CHANG S.L., Ewing A., Blake J., Tobin T. Hordenine: Pharmacology, pharmacokinetics and behavioural effects in the horse. Equine Vet. J. 1990;22:437\u2013441. doi: 10.1111/j.2042-3306.1990.tb04312.x.", "ArticleIdList": ["10.1111/j.2042-3306.1990.tb04312.x", "2269269"]}, {"Citation": "Hapke H., Strathmann W. Pharmacological effects of hordenine. Dtw. Dtsch. Tierarztl. Wochenschr. 1995;102:228\u2013232.", "ArticleIdList": ["8582256"]}, {"Citation": "Anwar S., Kar R.K., Haque M.A., Dahiya R., Gupta P., Islam A., Ahmad F., Hassan M.I. Effect of pH on the structure and function of pyruvate dehydrogenase kinase 3: Combined spectroscopic and MD simulation studies. Int. J. Biol. Macromol. 2020;147:768\u2013777. doi: 10.1016/j.ijbiomac.2020.01.218.", "ArticleIdList": ["10.1016/j.ijbiomac.2020.01.218", "31982536"]}, {"Citation": "Dahiya R., Mohammad T., Gupta P., Haque A., Alajmi M.F., Hussain A., Hassan M.I. Molecular interaction studies on ellagic acid for its anticancer potential targeting pyruvate dehydrogenase kinase 3. RSC Adv. 2019;9:23302\u201323315. doi: 10.1039/C9RA02864A.", "ArticleIdList": ["10.1039/C9RA02864A", "PMC9067284", "35514501"]}, {"Citation": "Chi Z., Liu R. Phenotypic characterization of the binding of tetracycline to human serum albumin. Biomacromolecules. 2010;12:203\u2013209. doi: 10.1021/bm1011568.", "ArticleIdList": ["10.1021/bm1011568", "21142141"]}, {"Citation": "Shamsi A., Mohammad T., Khan M.S., Shahwan M., Husain F.M., Rehman M., Hassan M., Ahmad F., Islam A. Unraveling Binding Mechanism of Alzheimer\u2019s Drug Rivastigmine Tartrate with Human Transferrin: Molecular Docking and Multi-Spectroscopic Approach towards Neurodegenerative Diseases. Biomolecules. 2019;9:495. doi: 10.3390/biom9090495.", "ArticleIdList": ["10.3390/biom9090495", "PMC6770857", "31533274"]}, {"Citation": "Gupta P., Khan F.I., Roy S., Anwar S., Dahiya R., Alajmi M.F., Hussain A., Rehman M.T., Lai D., Hassan M.I. Functional implications of pH-induced conformational changes in the Sphingosine kinase 1. Spectrochim. Acta Mol. Biomol. Spectrosc. 2020;225:117453. doi: 10.1016/j.saa.2019.117453.", "ArticleIdList": ["10.1016/j.saa.2019.117453", "31446356"]}, {"Citation": "Khan P., Rahman S., Queen A., Manzoor S., Naz F., Hasan G.M., Luqman S., Kim J., Islam A., Ahmad F., et al. Elucidation of Dietary Polyphenolics as Potential Inhibitor of Microtubule Affinity Regulating Kinase 4: In silico and In vitro Studies. Sci. Rep. 2017;7:9470. doi: 10.1038/s41598-017-09941-4.", "ArticleIdList": ["10.1038/s41598-017-09941-4", "PMC5573368", "28842631"]}, {"Citation": "Voura M., Khan P., Thysiadis S., Katsamakas S., Queen A., Hasan G.M., Ali S., Sarli V., Hassan M.I. Probing the Inhibition of Microtubule Affinity Regulating Kinase 4 by N-Substituted Acridones. Sci. Rep. 2019;9:1676. doi: 10.1038/s41598-018-38217-8.", "ArticleIdList": ["10.1038/s41598-018-38217-8", "PMC6368574", "30737440"]}, {"Citation": "Kato M., Chuang J.L., Tso S.C., Wynn R.M., Chuang D.T. Crystal structure of pyruvate dehydrogenase kinase 3 bound to lipoyl domain 2 of human pyruvate dehydrogenase complex. EMBO J. 2005;24:1763\u20131774. doi: 10.1038/sj.emboj.7600663.", "ArticleIdList": ["10.1038/sj.emboj.7600663", "PMC1142596", "15861126"]}, {"Citation": "Jacob R.B., Andersen T., McDougal O.M. Accessible high-throughput virtual screening molecular docking software for students and educators. PLoS Comput. Biol. 2012;8:e1002499. doi: 10.1371/journal.pcbi.1002499.", "ArticleIdList": ["10.1371/journal.pcbi.1002499", "PMC3364939", "22693435"]}, {"Citation": "Mohammad T., Batra S., Dahiya R., Baig M.H., Rather I.A., Dong J.J., Hassan I. Identification of High-Affinity Inhibitors of Cyclin-Dependent Kinase 2 Towards Anticancer Therapy. Molecules. 2019;24:4589. doi: 10.3390/molecules24244589.", "ArticleIdList": ["10.3390/molecules24244589", "PMC6943647", "31847444"]}, {"Citation": "Mohammad T., Siddiqui S., Shamsi A., Alajmi M.F., Hussain A., Islam A., Ahmad F., Hassan M.I. Virtual Screening Approach to Identify High-Affinity Inhibitors of Serum and Glucocorticoid-Regulated Kinase 1 among Bioactive Natural Products: Combined Molecular Docking and Simulation Studies. Molecules. 2020;25:823. doi: 10.3390/molecules25040823.", "ArticleIdList": ["10.3390/molecules25040823", "PMC7070812", "32070031"]}, {"Citation": "Abraham M.J., Murtola T., Schulz R., P\u00e1ll S., Smith J.C., Hess B., Lindahl E. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1:19\u201325. doi: 10.1016/j.softx.2015.06.001.", "ArticleIdList": ["10.1016/j.softx.2015.06.001"]}, {"Citation": "Dahiya R., Mohammad T., Roy S., Anwar S., Gupta P., Haque A., Khan P., Kazim S.N., Islam A., Ahmad F. Investigation of inhibitory potential of quercetin to the pyruvate dehydrogenase kinase 3: Towards implications in anticancer therapy. Int. J. Biol. Macromol. 2019;136:1076\u20131085. doi: 10.1016/j.ijbiomac.2019.06.158.", "ArticleIdList": ["10.1016/j.ijbiomac.2019.06.158", "31233792"]}, {"Citation": "Humphrey W., Dalke A., Schulten K. VMD: Visual molecular dynamics. J. Mol. Graph. 1996;14:33\u201338. doi: 10.1016/0263-7855(96)00018-5.", "ArticleIdList": ["10.1016/0263-7855(96)00018-5", "8744570"]}, {"Citation": "Ali S., Khan F.I., Mohammad T., Lan D., Hassan M., Wang Y. Identification and Evaluation of Inhibitors of Lipase from Malassezia restricta using Virtual High-Throughput Screening and Molecular Dynamics Studies. Int. J. Mol. Sci. 2019;20:884. doi: 10.3390/ijms20040884.", "ArticleIdList": ["10.3390/ijms20040884", "PMC6412828", "30781686"]}, {"Citation": "Mohammad T., Khan F.I., Lobb K.A., Islam A., Ahmad F., Hassan M.I. Identification and evaluation of bioactive natural products as potential inhibitors of human microtubule affinity-regulating kinase 4 (MARK4) J. Biomol. Struct. Dyn. 2019;37:1813\u20131829. doi: 10.1080/07391102.2018.1468282.", "ArticleIdList": ["10.1080/07391102.2018.1468282", "29683402"]}, {"Citation": "Naqvi A.A., Mohammad T., Hasan G.M., Hassan M. Advancements in docking and molecular dynamics simulations towards ligand-receptor interactions and structure-function relationships. Curr. Top. Med. Chem. 2018;18:1755\u20131768. doi: 10.2174/1568026618666181025114157.", "ArticleIdList": ["10.2174/1568026618666181025114157", "30360721"]}, {"Citation": "Koukourakis M.I., Giatromanolaki A., Sivridis E., Gatter K.C., Harris A.L., Tumor and Angiogenesis Research Group Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma. Neoplasia. 2005;7:1\u20136. doi: 10.1593/neo.04373.", "ArticleIdList": ["10.1593/neo.04373", "PMC1490315", "15736311"]}, {"Citation": "Queen A., Khan P., Idrees D., Azam A., Hassan M.I. Biological evaluation of p-toluene sulphonylhydrazone as carbonic anhydrase IX inhibitors: An approach to fight hypoxia-induced tumors. Int. J. Biol. Macromol. 2018;106:840\u2013850. doi: 10.1016/j.ijbiomac.2017.08.082.", "ArticleIdList": ["10.1016/j.ijbiomac.2017.08.082", "28830777"]}, {"Citation": "Aneja B., Queen A., Khan P., Shamsi F., Hussain A., Hasan P., Rizvi M.M.A., Daniliuc C.G., Alajmi M.F., Mohsin M., et al. Design, synthesis & biological evaluation of ferulic acid-based small molecule inhibitors against tumor-associated carbonic anhydrase IX. Bioorg Med. Chem. 2020;28:115424. doi: 10.1016/j.bmc.2020.115424.", "ArticleIdList": ["10.1016/j.bmc.2020.115424", "32209296"]}, {"Citation": "Kuzmanic A., Zagrovic B. Determination of ensemble-average pairwise root mean-square deviation from experimental B-factors. Biophys. J. 2010;98:861\u2013871. doi: 10.1016/j.bpj.2009.11.011.", "ArticleIdList": ["10.1016/j.bpj.2009.11.011", "PMC2830444", "20197040"]}, {"Citation": "Beg A., Khan F.I., Lobb K.A., Islam A., Ahmad F., Hassan M.I. High throughput screening, docking, and molecular dynamics studies to identify potential inhibitors of human calcium/calmodulin-dependent protein kinase IV. J. Biomol. Struct. Dyn. 2019;37:2179\u20132192. doi: 10.1080/07391102.2018.1479310.", "ArticleIdList": ["10.1080/07391102.2018.1479310", "30044185"]}, {"Citation": "Rodier F., Bahadur R.P., Chakrabarti P., Janin J. Hydration of protein\u2013protein interfaces. Proteins Struct. Funct. Bioinform. 2005;60:36\u201345. doi: 10.1002/prot.20478.", "ArticleIdList": ["10.1002/prot.20478", "15856483"]}, {"Citation": "Ali S.A., Hassan M.I., Islam A., Ahmad F. A review of methods available to estimate solvent-accessible surface areas of soluble proteins in the folded and unfolded states. Curr. Protein Pept. Sci. 2014;15:456\u2013476. doi: 10.2174/1389203715666140327114232.", "ArticleIdList": ["10.2174/1389203715666140327114232", "24678666"]}, {"Citation": "Hubbard R.E., Kamran Haider M. eLS. John Wiley & Sons, Ltd.; Hoboken, NJ, USA: 2001. Hydrogen Bonds in Proteins: Role and Strength."}, {"Citation": "Khan P., Queen A., Mohammad T., Smita, Khan N.S., Hafeez Z.B., Hassan M.I., Ali S. Identification of alpha-Mangostin as a Potential Inhibitor of Microtubule Affinity Regulating Kinase 4. J. Nat. Prod. 2019;82:2252\u20132261. doi: 10.1021/acs.jnatprod.9b00372.", "ArticleIdList": ["10.1021/acs.jnatprod.9b00372", "31343173"]}, {"Citation": "Shamsi A., Ahmed A., Khan M.S., Husain F.M., Amani S., Bano B. Investigating the interaction of anticancer drug temsirolimus with human transferrin: Molecular docking and spectroscopic approach. J. Mol. Recognit. 2018;31:e2728. doi: 10.1002/jmr.2728.", "ArticleIdList": ["10.1002/jmr.2728", "29770561"]}, {"Citation": "Jameel E., Naz H., Khan P., Tarique M., Kumar J., Mumtazuddin S., Ahamad S., Islam A., Ahmad F., Hoda N., et al. Design, synthesis, and biological evaluation of pyrimidine derivatives as potential inhibitors of human calcium/calmodulin-dependent protein kinase IV. Chem. Biol. Drug Des. 2017;89:741\u2013754. doi: 10.1111/cbdd.12898.", "ArticleIdList": ["10.1111/cbdd.12898", "27809417"]}, {"Citation": "Naz H., Tarique M., Khan P., Luqman S., Ahamad S., Islam A., Ahmad F., Hassan M.I. Evidence of vanillin binding to CAMKIV explains the anti-cancer mechanism in human hepatic carcinoma and neuroblastoma cells. Mol. Cell Biochem. 2018;438:35\u201345. doi: 10.1007/s11010-017-3111-0.", "ArticleIdList": ["10.1007/s11010-017-3111-0", "28744811"]}, {"Citation": "Xu J., Shi Q., Xu W., Zhou Q., Shi R., Ma Y., Chen D., Zhu L., Feng L., Cheng A.S., et al. Metabolic enzyme PDK3 forms a positive feedback loop with transcription factor HSF1 to drive chemoresistance. Theranostics. 2019;9:2999\u20133013. doi: 10.7150/thno.31301.", "ArticleIdList": ["10.7150/thno.31301", "PMC6568185", "31244938"]}, {"Citation": "Naz F., Anjum F., Islam A., Ahmad F., Hassan M.I. Microtubule affinity-regulating kinase 4: Structure, function, and regulation. Cell Biochem. Biophys. 2013;67:485\u2013499. doi: 10.1007/s12013-013-9550-7.", "ArticleIdList": ["10.1007/s12013-013-9550-7", "23471664"]}, {"Citation": "Naz H., Islam A., Ahmad F., Hassan M.I. Calcium/calmodulin-dependent protein kinase IV: A multifunctional enzyme and potential therapeutic target. Prog. Biophys. Mol. Biol. 2016;121:54\u201365. doi: 10.1016/j.pbiomolbio.2015.12.016.", "ArticleIdList": ["10.1016/j.pbiomolbio.2015.12.016", "26773169"]}, {"Citation": "Hoda N., Naz H., Jameel E., Shandilya A., Dey S., Hassan M.I., Ahmad F., Jayaram B. Curcumin specifically binds to the human calcium-calmodulin-dependent protein kinase IV: Fluorescence and molecular dynamics simulation studies. J. Biomol. Struct Dyn. 2016;34:572\u2013584. doi: 10.1080/07391102.2015.1046934.", "ArticleIdList": ["10.1080/07391102.2015.1046934", "25929263"]}, {"Citation": "Hassan M.I. Editorial. Recent Advances in the Structure-Based Drug Design and Discovery. Curr. Top. Med. Chem. 2016;16:899\u2013900. doi: 10.2174/1568026616999150918145640.", "ArticleIdList": ["10.2174/1568026616999150918145640", "26381417"]}, {"Citation": "Kaul R., Risinger A.L., Mooberry S.L. Microtubule-Targeting Drugs: More than Antimitotics. J. Nat. Prod. 2019;82:680\u2013685. doi: 10.1021/acs.jnatprod.9b00105.", "ArticleIdList": ["10.1021/acs.jnatprod.9b00105", "30835122"]}, {"Citation": "Hern\u00e1ndez-Bolio G.I., Ruiz-Vargas J.A., Pe\u00f1a-Rodr\u00edguez L.M. Natural Products from the Yucatecan Flora: Structural Diversity and Biological Activity. J. Nat. Prod. 2019;82:647\u2013656. doi: 10.1021/acs.jnatprod.8b00959.", "ArticleIdList": ["10.1021/acs.jnatprod.8b00959", "30855145"]}, {"Citation": "Yang R., Guo C. Discovery of potent pyruvate dehydrogenase kinase inhibitors and evaluation of their anti-lung cancer activity under hypoxia. Medchemcomm. 2018;9:1843\u20131849. doi: 10.1039/C8MD00453F.", "ArticleIdList": ["10.1039/C8MD00453F", "PMC6253843", "30568752"]}, {"Citation": "Sur S., Nakanishi H., Flaveny C., Ippolito J.E., McHowat J., Ford D.A., Ray R.B. Inhibition of the key metabolic pathways, glycolysis and lipogenesis, of oral cancer by bitter melon extract. Cell Commun. Signal. 2019;17:131. doi: 10.1186/s12964-019-0447-y.", "ArticleIdList": ["10.1186/s12964-019-0447-y", "PMC6802351", "31638999"]}, {"Citation": "Feng L., Cheng K., Zang R., Wang Q., Wang J. miR-497-5p inhibits gastric cancer cell proliferation and growth through targeting PDK3. Biosci. Rep. 2019;39 doi: 10.1042/BSR20190654.", "ArticleIdList": ["10.1042/BSR20190654", "PMC6732365", "31409724"]}]}], "History": [{"Year": "2020", "Month": "4", "Day": "14"}, {"Year": "2020", "Month": "5", "Day": "9"}, {"Year": "2020", "Month": "5", "Day": "11"}, {"Year": "2020", "Month": "5", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "20", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "5", "Day": "14"}], "PublicationStatus": "epublish", "ArticleIdList": ["32422877", "PMC7277448", "10.3390/biomedicines8050119", "biomedicines8050119"]}}]}